Spinal Tech

Biomaterials Market Estimated at $88.4B by 2017

A recent MarketsandMarkets report estimated the biomaterials market to be worth $88.4 billion by 2017, increasing at a compound annual growth rate of 15 percent between 2012 and 2017.

Carrie Pallardy

Tuesday, April 2nd, 2013

The report profiles companies that will play a large role in driving the biomaterials market, including the U.K.-based biomaterial solutions company Invibio.

More Articles on Devices and Implants
11 News Updates for Orthopedic Device Companies
OrthoData Device Gauges Spine Fusion Success
7 New Orthopedic Device Launches & Releases

Next Up in Spinal Tech

Where AI 'actually makes a difference' in spine care: Dr. David Skaggs

AI in spine care has been commonly leveraged to support administrative tasks, but one of its real potentials lies in…

By: Carly Behm
Wednesday, November 19th, 2025
Stryker net sales up 10.3% in Q3: 5 notes

Medtech company Stryker reported sales increases across multiple portfolios in the third quarter, according to financial results posted Oct. 30.…

By: Ariana Portalatin
Friday, October 31st, 2025
4 spine FDA nods in October

Here are four companies earning FDA clearance for spine technology this month: 1. Elevation Spine’s Saber-C earned FDA clearance for…

By: Ariana Portalatin
Friday, October 31st, 2025

Comments are closed.

How physician leaders are reshaping surgical ops: Lessons from WakeMed, Lee Health + more

Next Up in Spinal Tech

Where AI 'actually makes a difference' in spine care: Dr. David Skaggs

Stryker net sales up 10.3% in Q3: 5 notes

4 spine FDA nods in October

Join the spine leaders & surgeons who start their day with Becker's